Monoclonal antibody specific for IDH1 R132H mutation
- PMID: 19798509
- DOI: 10.1007/s00401-009-0595-z
Monoclonal antibody specific for IDH1 R132H mutation
Abstract
IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraffin embedded tumor specimens. This antibody is highly useful for tumor classification, in detecting single infiltrating tumor cells and for the characterization of the cellular role of mutant IDH1 protein.
Comment in
-
GFAP, Ki67 and IDH1: perhaps the golden triad of glioma immunohistochemistry.Acta Neuropathol. 2009 Nov;118(5):603-4. doi: 10.1007/s00401-009-0600-6. Acta Neuropathol. 2009. PMID: 19847448 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
